Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women.
Moorman
Patricia G
PG
Cancer Prevention, Detection and Control Research Program, Department of Community and Family Medicine, Duke University Medical Center, Suite 602, Box 2949, 2424 Erwin Road, Durham, NC 27710, USA. patricia.moorman@duke.edu
Sesay
John
J
Nwosu
Veronica
V
Kane
Janet Grubber
JG
de Cotret
Allan René
AR
Worley
Kendra
K
Millikan
Robert
R
D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D044383:Black People; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000235:genetics* / Q000517:prevention & control; D051546:Cyclooxygenase 2 / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D016015:Logistic Models; D008875:Middle Aged; D009657:North Carolina / Q000453:epidemiology; D011110:Polymorphism, Genetic; D014481:United States / Q000453:epidemiology; D001741:Black or African American
D000894:Anti-Inflammatory Agents, Non-Steroidal; D051546:Cyclooxygenase 2